Patents Assigned to Herantis Pharma Oyj
  • Treatment with a pharmaceutical composition comprising MANF2 necleic acid
    Patent number: 8980821
    Abstract: A method for treating a condition in a patient, wherein the condition is selected from the group consisting of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, stroke and peripheral neuropathy. The method consists of administering to the patient a pharmaceutically effective amount of a pharmaceutical composition comprising the MANF2 polypeptide of SEQ ID NO:2 or a functional fragment thereof.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: March 17, 2015
    Assignee: Herantis Pharma Oyj
    Inventors: Mart Saarma, Juha Lauren, Päivi Lindholm, Tonis Timmusk, Raimo Tuominen